Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease

被引:0
|
作者
Perry K. Pratt
David Nunes
Michelle T. Long
Francis A. Farraye
机构
[1] University of Connecticut Health,Division of Gastroenterology and Hepatology
[2] Boston University Medical Center,Section of Gastroenterology
来源
关键词
Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Hepatitis B virus immunity; Hepatitis B virus vaccination failure; Booster; Revaccination;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2031 / 2038
页数:7
相关论文
共 50 条
  • [31] Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination
    Cossio-Gil, Yolima
    Martinez-Gomez, Xavier
    Campins-Marti, Magda
    Angel Rodrigo-Pendas, Jose
    Borruel-Sainz, Natalia
    Rodriguez-Frias, Francisco
    Casellas-Jorda, Francesc
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (01) : 92 - 98
  • [32] Hepatitis B vaccination in liver cirrhosis: additional doses increase response rate
    Simon, Annika
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (06):
  • [33] Evaluation of Antibody Response to Polysaccharide Vaccine and Switched Memory B Cells in Pediatric Patients with Inflammatory Bowel Disease
    Fallahi, Gholamhossein
    Aghamohammadi, Asghar
    Khodadad, Ahmad
    Hashemi, Mojtaba
    Mohammadinejad, Payam
    Asgarian-Omran, Hossein
    Najafi, Mehri
    Farhmand, Fatemeh
    Motamed, Farzaneh
    Soleimani, Khadije
    Soheili, Habib
    Parvaneh, Nima
    Darabi, Behzad
    Kalmarzi, Rasoul Nasiri
    Pourhamdi, Shabnam
    Abolhassani, Hassan
    Mirminachi, Babak
    Rezaei, Nima
    GUT AND LIVER, 2014, 8 (01) : 24 - 28
  • [34] Strong Response to SARS-CoV-2 Vaccine Additional Doses among Patients with Inflammatory Bowel Diseases
    Kappelman, M.
    Weaver, K.
    Zhang, X.
    Chun, K.
    Long, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I586 - I587
  • [35] Strong Response to SARS-CoV-2 Vaccine Additional Doses among Patients with Inflammatory Bowel Diseases
    Kappelman, M.
    Weaver, K.
    Zhang, X.
    Chun, K.
    Long, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I586 - I587
  • [36] A comparison of two Fendrix hepatitis B vaccination schedules in patients with inflammatory bowel disease
    Kuiper, Vincent P.
    van der Plas, Pauline
    Hoogerwerf, Marie-Astrid
    Koopman, Jan Pieter R.
    van der Meulen, Andrea E.
    Roukens, Anna H. E.
    Visser, Leo G.
    Roestenberg, Meta
    VACCINE, 2022, 40 (43) : 6201 - 6205
  • [37] Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis
    Kochhar, Gursimran S.
    Mohan, Babu P.
    Khan, Shahab R.
    Chandan, Saurabh
    Kassab, Lena L.
    Ponnada, Suresh
    Desai, Aakash
    Caldera, Freddy
    Dulai, Parambir S.
    Farraye, Francis A.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (10) : 1610 - 1619
  • [38] Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases
    Long, Millie D.
    Weaver, Kimberly N.
    Zhang, Xian
    Chun, Kelly
    Kappelman, Michael D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) : 1881 - +
  • [39] Effect of immunosuppressive treatment in the efficacy of Hepatitis B vaccine in patients with inflammatory bowel disease
    Santos-Antunes, J.
    Andrade, P.
    Rodrigues, S.
    Magro, F.
    Lopes, S.
    Macedo, G.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S277 - S277
  • [40] Hepatitis B Immunity and Response to Booster Vaccination in Children With Inflammatory Bowel Disease Treated With Infliximab
    Moses, Jonathan
    Alkhouri, Naim
    Shannon, Angela
    Raig, Kathy
    Lopez, Rocio
    Danziger-Isakov, Lara
    Feldstein, Ariel E.
    Zein, Nizar N.
    Wyllie, Robert
    Carter-Kent, Christine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (01): : 133 - 138